VeriMomphaseolus vulgaris phytoplacenta extract hamilelikte güvenli mi?
No harmonised CLP reproductive classifications (ECHA Annex VI), no SCCS or CIR safety assessment flagging reproductive hazard, and no peer-reviewed evidence of teratogenicity or reproductive toxicity for Phaseolus vulgaris phytoplacenta extract were identified in available databases. Botanical extracts of this type are typically high‑molecular-weight mixtures unlikely to be systemically bioactive when applied topically (sources: ECHA Annex VI, CosIng, PubMed literature search absent specific reproductive studies).
Related ingredients
Frequently asked questions
- phaseolus vulgaris phytoplacenta extract hamilelikte güvenli mi?
- No harmonised CLP reproductive classifications (ECHA Annex VI), no SCCS or CIR safety assessment flagging reproductive hazard, and no peer-reviewed evidence of teratogenicity or reproductive toxicity for Phaseolus vulgaris phytoplacenta extract were identified in available databases. Botanical extracts of this type are typically high‑molecular-weight mixtures unlikely to be systemically bioactive when applied topically (sources: ECHA Annex VI, CosIng, PubMed literature search absent specific reproductive studies).
- phaseolus vulgaris phytoplacenta extract emzirirken güvenli mi?
- No data indicating mammary transfer or lactation-related hazards; no harmonised or authoritative reviews raising concerns. Given lack of evidence for systemic reproductive toxicity and probable limited dermal absorption for a plant placental extract, risk via breastmilk is not indicated (sources: CosIng, PubMed, ECHA Annex VI absence).
- phaseolus vulgaris phytoplacenta extract bebek cildi için güvenli mi?
- Hazard (h) and mechanism (m): no infant-specific reproductive/toxicology evidence found. Exposure (e) increased to 1 because infant skin has higher surface-area-to-weight and a less mature barrier; although the extract is likely high‑molecular-weight and not readily absorbed, neonatal/infant percutaneous absorption can be greater, so low but measurable exposure is plausible for topical use (sources: CosIng, general dermal absorption principles).
- VeriMom phaseolus vulgaris phytoplacenta extract nasıl puanlıyor?
- VeriMom phaseolus vulgaris phytoplacenta extract'yi EU CosIng, ECHA sınıflandırmaları ve PubMed çalışmalarına göre 100/100 (bilinen risk yok) olarak puanlar.
- Hamilelikte phaseolus vulgaris phytoplacenta extract yerine neler kullanılabilir?
- Benzer işlevli ve bilinen riski olmayan alternatifleri içeren listemize bakın.
Her etiketi 2 saniyede kontrol et
VeriMom'u ücretsiz indirin — herhangi bir ürünü tarayın ve hamilelik güvenlik puanını anında görün.
Tıbbi Sorumluluk Reddi
Bu bilgiler yalnızca eğitim amaçlıdır ve tıbbi tavsiye niteliği taşımaz. Güvenlik puanları kamuya açık verilere dayanmaktadır ve tüm riskleri yansıtmayabilir. Hamilelik veya emzirme döneminde herhangi bir ürünü kullanmadan önce her zaman sağlık uzmanınıza danışın.